Sc.D. and M.S., epidemiology, Harvard T.H. Chan School of Public Health; B.S., chemical and biological engineering, Massachusetts Institute of Technology
Summary of Experience
Dr. Bobbili specializes in the application of statistical methods to the causal analysis of complex longitudinal data. She has a wide range of experience in epidemiology and health economics and outcomes research (HEOR), including studies on causal methods, drug adherence, and comparative effectiveness, particularly in the oncology disease area. Dr. Bobbili has experience designing and conducting studies using large, observational, and real-world data sources to emulate target trials. She has been involved in several studies to support US Food and Drug Administration (FDA) new drug applications (NDAs) and supplemental new drug applications (sNDAs), particularly real-world historical control studies to contextualize the results of clinical trials. Her work has been presented at multiple conferences and published in numerous peer-reviewed journals. Prior to joining Analysis Group, Dr. Bobbili served as a research assistant and teaching assistant at the Harvard T. H. Chan School of Public Health.
Health Care Resource Utilization and Costs Associated with Transitioning to 3-month Paliperidone Palmitate Among US Veterans
Clinical Therapeutics. 2018 Sep;40(9):1496-1508
Adherence to iron chelation therapy in patients who switched from deferasirox dispersible tablets to deferasirox film-coated tablets
Current Medical Research and Opinion. Apr 27 2018:1-14